BPC 157 Banned: Key Facts on the Latest FDA Decision The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions BPC 157: A MAHA Adjacent Peptide, Linked to Croatia BPC 157 Banned: Key Facts on the Latest FDA Decision